Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominique Heymann

Showing results (91-100 of 243) with videos related to

Pageof 25
Sort By:
Bone|June 6, 2006
OPG/membranous--RANKL complex is internalized via the clathrin pathway before a lysosomal and a proteasomal degradationSteeve Kwan Tat, Marc Padrines, Sandrine Theoleyre, et al.
Oncotarget|August 21, 2014
Clusterin inhibition using OGX-011 synergistically enhances zoledronic acid activity in osteosarcomaFrancois Lamoureux, Marc Baud'huin, Benjamin Ory, et al.
Cancer Letters|December 17, 2013
NVP-BEZ235, a dual PI3K/mTOR inhibitor, inhibits osteosarcoma cell proliferation and tumor development in vivo with an improved survival rateBérengère Gobin, Séverine Battaglia, Rachel Lanel, et al.
Arthritis Research & Therapy|December 17, 2009
A combination of methotrexate and zoledronic acid prevents bone erosions and systemic bone mass loss in collagen induced arthritisBenoit Le Goff, Elise Soltner, Céline Charrier, et al.
Drug Discovery Today|July 26, 2021
FVIII at the crossroad of coagulation, bone and immune biology: Emerging evidence of biological activities beyond hemostasisMarie Cadé, Javier Muñoz-Garcia, Antoine Babuty, et al.
Cancer|July 14, 2011
Synergistic inhibitory effect of apomine and lovastatin on osteosarcoma cell growthGatien Moriceau, Anke J Roelofs, Régis Brion, et al.
Journal of Bone Oncology|August 21, 2018
Isolation of circulating tumor cells in a preclinical model of osteosarcoma: Effect of chemotherapyAntoine Chalopin, Marta Tellez-Gabriel, Hannah K Brown, et al.
European Cells & Materials|January 18, 2013
Computational model combined with in vitro experiments to analyse mechanotransduction during mesenchymal stem cell adhesionJean-Louis Milan, Sandrine Lavenus, Paul Pilet, et al.
Marine Drugs|April 3, 2021
Antiproliferative Properties of Scandium Exopolysaccharide Complexes on Several Cancer Cell LinesJavier Muñoz-Garcia, Mattia Mazza, Cyrille Alliot, et al.
Biochemical Pharmacology|July 2, 2019
Genetically-achieved disturbances to the expression levels of TNFSF11 receptors modulate the effects of zoledronic acid on growing mouse skeletonsJorge William Vargas-Franco, Beatriz Castaneda, Andrea Gama, et al.
Pageof 25

Showing results (91-100 of 243) with videos related to

Sort By:
Pageof 25
Bone|June 6, 2006
OPG/membranous--RANKL complex is internalized via the clathrin pathway before a lysosomal and a proteasomal degradationSteeve Kwan Tat, Marc Padrines, Sandrine Theoleyre, et al.
Oncotarget|August 21, 2014
Clusterin inhibition using OGX-011 synergistically enhances zoledronic acid activity in osteosarcomaFrancois Lamoureux, Marc Baud'huin, Benjamin Ory, et al.
Cancer Letters|December 17, 2013
NVP-BEZ235, a dual PI3K/mTOR inhibitor, inhibits osteosarcoma cell proliferation and tumor development in vivo with an improved survival rateBérengère Gobin, Séverine Battaglia, Rachel Lanel, et al.
Arthritis Research & Therapy|December 17, 2009
A combination of methotrexate and zoledronic acid prevents bone erosions and systemic bone mass loss in collagen induced arthritisBenoit Le Goff, Elise Soltner, Céline Charrier, et al.
Drug Discovery Today|July 26, 2021
FVIII at the crossroad of coagulation, bone and immune biology: Emerging evidence of biological activities beyond hemostasisMarie Cadé, Javier Muñoz-Garcia, Antoine Babuty, et al.
Cancer|July 14, 2011
Synergistic inhibitory effect of apomine and lovastatin on osteosarcoma cell growthGatien Moriceau, Anke J Roelofs, Régis Brion, et al.
Journal of Bone Oncology|August 21, 2018
Isolation of circulating tumor cells in a preclinical model of osteosarcoma: Effect of chemotherapyAntoine Chalopin, Marta Tellez-Gabriel, Hannah K Brown, et al.
European Cells & Materials|January 18, 2013
Computational model combined with in vitro experiments to analyse mechanotransduction during mesenchymal stem cell adhesionJean-Louis Milan, Sandrine Lavenus, Paul Pilet, et al.
Marine Drugs|April 3, 2021
Antiproliferative Properties of Scandium Exopolysaccharide Complexes on Several Cancer Cell LinesJavier Muñoz-Garcia, Mattia Mazza, Cyrille Alliot, et al.
Biochemical Pharmacology|July 2, 2019
Genetically-achieved disturbances to the expression levels of TNFSF11 receptors modulate the effects of zoledronic acid on growing mouse skeletonsJorge William Vargas-Franco, Beatriz Castaneda, Andrea Gama, et al.
Pageof 25